Special report of the U.S. Senate Special Committee on Aging on the sudden price spikes in off-patent prescription drugs : the monopoly business model that harms patients, taxpayers, and the U.S. health system.
Saved in:
Corporate Author: | United States. Congress. Senate. Special Committee on Aging (Author) |
---|---|
Format: | Government Document Electronic eBook |
Language: | English |
Published: |
Washington :
U.S. Government Publishing Office,
2016.
|
Series: | Report / 114th Congress, 2d session, Senate ;
114-429 |
Subjects: | |
Online Access: | CONNECT |
Similar Items
-
Sudden price spikes in off-patent drugs : perspectives from the front lines : hearing before the Special Committee on Aging, United States Senate, One Hundred Fourteenth Congress, first session, Washington, DC, December 9, 2015.
Published: (2022) -
Sudden price spikes in decades-old prescription drugs : inside the monopoly business model : hearing before the Special Committee on Aging, United States Senate, One Hundred Fourteenth Congress, second session, Washington, DC, March 17, 2016.
Published: (2022) -
Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016.
Published: (2018) -
Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining generic drug user fee amendments, focusing on accelerating patient access to generic drugs, January 28, 2016.
Published: (2018) -
Preserve Access to Affordable Generics and Biosimilars Act : report together with additional views (to accompany H.R. 2375) (including cost estimate of the Congressional Budget Office).
Published: (2020)